Cutting-edge therapies exist, but the market cannot deliver them cheaply. Britain must build NHS capacity so that cures become collective goods, not expensive products Just a small fraction of our ...
The first successful gene-editing treatment for beta thalassaemia has been delivered at University College London Hospital (UCLH), marking a milestone for patients with the inherited blood disorder.
The biggest stories of the day delivered to your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback